BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park SH, Aniwan S, Scott Harmsen W, Tremaine WJ, Lightner AL, Faubion WA, Loftus EV. Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort. Inflamm Bowel Dis. 2019;25:1054-1060. [PMID: 30346531 DOI: 10.1093/ibd/izy329] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Dalal RS, Allegretti JR. Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All. Inflamm Bowel Dis 2021;27:e70. [PMID: 33570151 DOI: 10.1093/ibd/izab019] [Reference Citation Analysis]
2 Lee JL. Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease. Ann Coloproctol 2019;35:225-6. [PMID: 31725995 DOI: 10.3393/ac.2019.10.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn's disease.Nat Rev Dis Primers. 2020;6:22. [PMID: 32242028 DOI: 10.1038/s41572-020-0156-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 23.5] [Reference Citation Analysis]
4 Rakowsky S, Papamichael K, Cheifetz AS. Choosing the right biologic for complications of inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology. [DOI: 10.1080/17474124.2022.2036122] [Reference Citation Analysis]
5 Sørensen KM, Jensen CH, Sheikh SP, Qvist N, Sørensen JA. Treatment of Fistulizing Perianal Crohn's Disease by Autologous Microfat Enriched With Adipose-Derived Regenerative Cells. Inflamm Bowel Dis 2021:izab276. [PMID: 34791256 DOI: 10.1093/ibd/izab276] [Reference Citation Analysis]
6 Chen G, Pedarla V, Null KD, Cazzetta SE, Khan QR, Schwartz DA. Health Care Costs and Resource Utilization Among Patients With Crohn's Disease With and Without Perianal Fistula. Inflamm Bowel Dis 2021:izab198. [PMID: 34525184 DOI: 10.1093/ibd/izab198] [Reference Citation Analysis]
7 Geldof J, Iqbal N, Warusavitarne J, Hart A. The Essential Role of a Multidisciplinary Approach in Inflammatory Bowel Diseases: Combined Medical-Surgical Treatment in Complex Perianal Fistulas in CD. Clin Colon Rectal Surg 2022;35:021-31. [DOI: 10.1055/s-0041-1740035] [Reference Citation Analysis]
8 Wiseman J, Chawla T, Morin F, de Buck van Overstraeten A, Weizman AV. A Multi-Disciplinary Approach to Perianal Fistulizing Crohn's Disease. Clin Colon Rectal Surg 2022;35:051-7. [DOI: 10.1055/s-0041-1740038] [Reference Citation Analysis]
9 Abramowitz L, Brochard C, Pigot F, Roumeguere P, Pillant H, Vinson Bonnet B, Faucheron JL, Senéjoux A, Bonnaud G, Meurette G, Fayette JM, Train C, Staumont G, Siproudhis L, Bouchard D. Surgical closure, mainly with glue injection and anti-tumour necrosis factor α, in fistulizing perianal Crohn's disease: A multicentre randomized controlled trial. Colorectal Dis 2021. [PMID: 34623746 DOI: 10.1111/codi.15947] [Reference Citation Analysis]
10 Seifarth C, Lehmann KS, Holmer C, Pozios I. Healing of rectal advancement flaps for anal fistulas in patients with and without Crohn's disease: a retrospective cohort analysis. BMC Surg 2021;21:283. [PMID: 34088303 DOI: 10.1186/s12893-021-01282-4] [Reference Citation Analysis]
11 Sun XL, Chen SY, Tao SS, Qiao LC, Chen HJ, Yang BL. Optimized timing of using infliximab in perianal fistulizing Crohn's disease. World J Gastroenterol 2020; 26(14): 1554-1563 [PMID: 32327905 DOI: 10.3748/wjg.v26.i14.1554] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Schwartz DA, Tagarro I, Carmen Díez M, Sandborn WJ. Prevalence of Fistulizing Crohn's Disease in the United States: Estimate From a Systematic Literature Review Attempt and Population-Based Database Analysis. Inflamm Bowel Dis 2019;25:1773-9. [PMID: 31216573 DOI: 10.1093/ibd/izz056] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
13 Deng F, Xia P, Wu Z, Zhou H, Wang X. Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn's Disease. Int J Gen Med 2021;14:3387-96. [PMID: 34285563 DOI: 10.2147/IJGM.S315505] [Reference Citation Analysis]
14 Brochard C, Rabilloud ML, Hamonic S, Bajeux E, Pagenault M, Dabadie A, Gerfaud A, Viel JF, Tron I, Robaszkiewicz M, Bretagne JF, Siproudhis L, Bouguen G;  Groupe ABERMAD. Natural History of Perianal Crohn's Disease: Long-term Follow-up of a Population-Based Cohort. Clin Gastroenterol Hepatol. 2020;. [PMID: 33359730 DOI: 10.1016/j.cgh.2020.12.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kim PH, Kim SH, Cho YA, Yoon HM, Lee JS, Jung AY, Oh SH, Kim DY, Namgoong JM, Kim KM. Ability of Pelvic Magnetic Resonance Imaging to Predict Clinical Course of Perianal Fistula in Paediatric Crohn's Disease Patients. J Crohns Colitis 2021;15:1152-60. [PMID: 33411884 DOI: 10.1093/ecco-jcc/jjab004] [Reference Citation Analysis]
16 Wewer MD, Zhao M, Nordholm-carstensen A, Weimers P, Seidelin JB, Burisch J. The Incidence and Disease Course of Perianal Crohn’s Disease: A Danish Nationwide Cohort Study, 1997–2015. Journal of Crohn's and Colitis 2021;15:5-13. [DOI: 10.1093/ecco-jcc/jjaa118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhu M, Xu X, Feng Q, Cui Z, Wang T, Yan Y, Ran Z. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease. Dig Dis Sci. 2021;66:1658-1668. [PMID: 32524415 DOI: 10.1007/s10620-020-06398-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Halligan S, Boone D, Archer L, Ahmad T, Bloom S, Rodriguez-Justo M, Taylor SA, Mallett S. Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review. Health Technol Assess 2021;25:1-66. [PMID: 34225839 DOI: 10.3310/hta25450] [Reference Citation Analysis]
19 Greer MC, Taylor SA. Perianal Imaging in Crohn Disease: Current Status With a Focus on MRI, From the AJR Special Series on Imaging of Inflammation. AJR Am J Roentgenol 2021. [PMID: 34549607 DOI: 10.2214/AJR.21.26615] [Reference Citation Analysis]
20 Abushamma S, Ballard DH, Smith RK, Deepak P. Multidisciplinary management of perianal Crohn's disease. Curr Opin Gastroenterol 2021;37:295-305. [PMID: 33899777 DOI: 10.1097/MOG.0000000000000751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Principi M, Labarile N, Bianchi FP, Contaldo A, Tafuri S, Ierardi E, Di Leo A. The Cost of Inflammatory Bowel Disease Management Matches with Clinical Course: A Single Outpatient Centre Analysis. Int J Environ Res Public Health 2020;17:E4549. [PMID: 32599816 DOI: 10.3390/ijerph17124549] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Song EM, Lee HS, Kim YJ, Oh EH, Ham NS, Kim J, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK. Clinical outcomes and long-term prognosis of perianal Crohn's disease in an Asian population. J Gastroenterol Hepatol 2021;36:1571-9. [PMID: 33091187 DOI: 10.1111/jgh.15308] [Reference Citation Analysis]
23 McCurdy JD, Reid J, Yanofsky R, Sinnathamby V, Medawar E, Williams L, Bessissow T, Rosenfeld G. Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study. Inflamm Bowel Dis 2021:izab086. [PMID: 33988225 DOI: 10.1093/ibd/izab086] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Nam K, Jung WB, Lee SB, Soh JS, Yang SS, Jung SW. Predictors of reoperation for perianal fistula in Crohn's disease. J Dig Dis 2021;22:334-41. [PMID: 33949127 DOI: 10.1111/1751-2980.12996] [Reference Citation Analysis]
25 Dalal RS, Njie C, Marcus J, Gupta S, Allegretti JR. Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification. Inflamm Bowel Dis 2021;27:1294-301. [PMID: 33146703 DOI: 10.1093/ibd/izaa282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
26 Lee JL, Yoon YS, Yu CS. Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon's Point of View. Ann Coloproctol 2021;37:5-15. [PMID: 33730796 DOI: 10.3393/ac.2021.02.08] [Reference Citation Analysis]
27 Papamichael K, Vande Casteele N, Jeyarajah J, Jairath V, Osterman MT, Cheifetz AS. Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis. Am J Gastroenterol 2021;116:1007-14. [PMID: 33929379 DOI: 10.14309/ajg.0000000000001111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Johnson S, Ko J, Halabi WJ, Stondell J, Dave M. Fistula Healing Is Low After Fecal Diversion Surgery in Perianal Crohn's Disease. Inflamm Bowel Dis 2021:izab210. [PMID: 34448837 DOI: 10.1093/ibd/izab210] [Reference Citation Analysis]
29 Hirsch RD, Keung C, Con D, Vasudevan A, Van Langenberg DR, Niewiadomski O. Direct health care costs of managing perianal Crohn's Disease in a population based cohort. Scand J Gastroenterol 2021;:1-7. [PMID: 34932436 DOI: 10.1080/00365521.2021.2016944] [Reference Citation Analysis]
30 Lightner AL. Cell-based therapy for Crohn's disease: time to consider optimization. Nat Rev Gastroenterol Hepatol 2019;16:137-8. [PMID: 30532061 DOI: 10.1038/s41575-018-0095-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Meyer J, Ris F, Parkes M, Davies J. Rectovaginal Fistula in Crohn's Disease: When and How to Operate? Clin Colon Rectal Surg 2022;35:010-20. [DOI: 10.1055/s-0041-1740029] [Reference Citation Analysis]
32 Le Berre C, Peyrin-Biroulet L; SPIRIT-IOIBD study group. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD. Gastroenterology 2021;160:1452-1460.e21. [PMID: 33421515 DOI: 10.1053/j.gastro.2020.10.065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
33 Williams JL, Shaffer VO. Modern Management of Perianal Crohn's Disease: A Review. Am Surg 2020;:3134820956331. [PMID: 33345571 DOI: 10.1177/0003134820956331] [Reference Citation Analysis]
34 Lightner AL. Perianal Crohn's Disease. Dis Colon Rectum. 2020;63:1023-1026. [PMID: 32692067 DOI: 10.1097/dcr.0000000000001748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Tsai L, McCurdy JD, Ma C, Jairath V, Singh S. Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts. Inflamm Bowel Dis 2021:izab287. [PMID: 34792604 DOI: 10.1093/ibd/izab287] [Reference Citation Analysis]
36 Iglay K, Bennett D, Kappelman MD, Thai S, Aldridge M, Karki C, Cook SF. A systematic review of the patient burden of Crohn’s disease-related rectovaginal and anovaginal fistulas. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-021-02079-8] [Reference Citation Analysis]